Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 10, 2016 8:54 AM ET

Diversified Consumer Services

Company Overview of Emory University

Company Overview

Emory University is an educational that offers undergraduate and graduate courses in the fields of arts and sciences, medicine, theology, law, nursing, public health, and business. Emory University was founded in 1836 and is based in Atlanta, Georgia.

201 Dowman Drive

Atlanta, GA 30322

United States

Founded in 1836

Phone:

404-727-6123

Fax:

404-727-4303

Key Executives for Emory University

Chancellor
Chief Environmental Officer
Vice President for Global Health
Age: 70
Executive Vice President for Health Affairs
Compensation as of Fiscal Year 2015.

Emory University Key Developments

AIDS Healthcare Foundation Begins Legal Battle to Strip Gilead Sciences Inc of Patents on HIV/AIDS Drug Genvoya

AIDS Healthcare Foundation (AHF) is suing Gilead Sciences Inc, looking to persuade a California district court to invalidate patents on the company's HIV/AIDS drug Genvoya (elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide). Gilead has resorted to patent system manipulation and anti-competitive practices in its relentless pursuit of maximum profits. The lawsuit focuses on patents related to Tenofovir, one of the compounds included in Gilead's TAF-based oral regimen. As AHF notes in its court filing, Tenofovir was first synthesised more than three decades ago in the Czech Republic so it is anything but a new compound. AHF has also named Japan Tobacco Inc. and Emory University among the defendants, claiming they have assisted Gilead in its attempt to extend the patent exclusivity period for medicines containing Tenofovir. The pharma group has manipulated the system by signing a licensing agreement with Japan Tobacco and using a pre-existing patent licensing agreement with Emory University as a way of preventing potential rival entry into the market and stifling competition. AHF has sustained direct damage as a result of Gilead's actions because the organisation has spent millions of dollars on Gilead drugs last year alone. AHF filed a complaint against Gilead with the US Food and Drug Administration (FDA), alerting the regulator that the company is promoting off-label use of its HIV/AIDS therapy Truvada. In a letter sent to FDA Acting Commissioner Stephen Ostroff, the organisation drew his attention to the fact that Gilead is among the sponsors of a video advertisement that promotes the situational use of Truvada for pre-exposure prophylaxis to prevent HIV infection. In this way, Gilead is giving viewers the wrong impression they can safely and effectively use Truvada on a situational basis although the drug has not been approved by the FDA for use in such way.

Emory University Appoints Jonathan S Lewin, MD as Executive Vice President for Health Affairs, Effective Feb. 1, 2016

Emory University announced that Jonathan S. Lewin, MD, has been appointed executive vice president for health affairs. Lewin also will serve as executive director for Emory's Woodruff Health Sciences Center, president and CEO of Emory Healthcare and chair of the Board of Directors of Emory Healthcare. He will begin his tenure at Emory on Feb. 1, 2016. Lewin currently serves as senior vice president for integrated healthcare delivery and as co-chair for strategic planning for Johns Hopkins Medicine.

Celtic Biotech Enters into Research Agreement with Emory University

Spotlight Innovation reported that its subsidiary Celtic Biotech recently entered into a Research Agreement with Emory University. The phase I study will be designed and conducted by an Emory University research team with the specific aim of demonstrating that the cell penetrating peptide Crotamine can be made into a suitable radiopharmaceutical for imaging lung cancer tumors with positron emission tomography (PET) in a clinical setting.

Similar Private Companies By Industry

Company Name Region
Northern Westchester School of Hairdressing and Cosmetology, Inc. United States
Oregon Wedding Photographer United States
Stepping Stones Museum For Children, Inc. United States
Glasspro Inc. United States
Brown Bag Naturals United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
April 2, 2015
Emory Healthcare, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Emory University, please visit www.emory.edu. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.